{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:57:34Z","timestamp":1790913454265,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41401-018-0078-7","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T07:44:21Z","timestamp":1540971861000},"page":"425-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses"],"prefix":"10.1038","volume":"40","author":[{"given":"Dan-dan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-feng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha-sha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-bi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-di","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-da","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-shuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-ping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"78_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/psyg.12053","volume":"14","author":"EH Kua","year":"2014","unstructured":"Kua EH, Ho E, Tan HH, Tsoi C, Thng C, Mahendran R. The natural history of dementia. Psychogeriatrics. 2014;14:196\u2013201.","journal-title":"Psychogeriatrics"},{"key":"78_CR2","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O\u2019Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A. Vascular dementia. Lancet. 2015;386:1698\u2013706.","journal-title":"Lancet"},{"key":"78_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1747-4949.2011.00731.x","volume":"7","author":"R Sahathevan","year":"2012","unstructured":"Sahathevan R, Brodtmann A, Donnan GA. Dementia, stroke, and vascular risk factors; a review. Int J Stroke. 2012;7:61\u201373.","journal-title":"Int J Stroke"},{"key":"78_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jns.2012.03.027","volume":"322","author":"AD Korczyn","year":"2012","unstructured":"Korczyn AD, Vakhapova V, Grinberg LT. Vascular dementia. J Neurol Sci. 2012;322:2\u201310.","journal-title":"J Neurol Sci"},{"key":"78_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.expneurol.2015.05.006","volume":"272","author":"P Venkat","year":"2015","unstructured":"Venkat P, Chopp M, Chen J. Models and mechanisms of vascular dementia. Exp Neurol. 2015;272:97\u2013108.","journal-title":"Exp Neurol"},{"key":"78_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/aps.2009.82","volume":"30","author":"J Wang","year":"2009","unstructured":"Wang J, Zhang HY, Tang XC. Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta Pharmacol Sin. 2009;30:879\u201388.","journal-title":"Acta Pharmacol Sin"},{"issue":"Suppl 3","key":"78_CR7","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.3233\/JAD-132639","volume":"42","author":"J Versijpt","year":"2014","unstructured":"Versijpt J. Effectiveness and cost-effectiveness of the pharmacological treatment of Alzheimer\u2019s disease and vascular dementia. J Alzheimer Dis. 2014;42(Suppl 3):S19\u201325.","journal-title":"J Alzheimer Dis"},{"key":"78_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCRESAHA.116.308426","volume":"120","author":"M Dichgans","year":"2017","unstructured":"Dichgans M, Leys D. Vascular cognitive impairment. Circ Res. 2017;120:573\u201391.","journal-title":"Circ Res"},{"key":"78_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.apsb.2014.10.004","volume":"4","author":"SF Chu","year":"2014","unstructured":"Chu SF, Zhang JT. Recent advances in the study of (-)clausenamide: chemistry, biological activities and mechanism of action. Acta Pharm Sin B. 2014;4:417\u201323.","journal-title":"Acta Pharm Sin B"},{"key":"78_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pharmthera.2016.01.002","volume":"162","author":"S Chu","year":"2016","unstructured":"Chu S, Liu S, Duan W, Cheng Y, Jiang X, Zhu C, et al. The anti-dementia drug candidate, (-)-clausenamide, improves memory impairment through its multi-target effect. Pharmacol Ther. 2016;162:179\u201387.","journal-title":"Pharmacol Ther"},{"key":"78_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1021\/np200919a","volume":"75","author":"H Liu","year":"2012","unstructured":"Liu H, Li CJ, Yang JZ, Ning N, Si YK, Li L, et al. Carbazole alkaloids from the stems of Clausena lansium. J Nat Prod. 2012;75:677\u201382.","journal-title":"J Nat Prod"},{"key":"78_CR12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3109\/10715762.2013.770150","volume":"47","author":"JW Li","year":"2013","unstructured":"Li JW, Ning N, Ma YZ, Zhang R, Tan F, Chen NH. Claulansine F suppresses apoptosis induced by sodium nitroprusside in PC12 cells. Free Radic Res. 2013;47:488\u201397.","journal-title":"Free Radic Res"},{"key":"78_CR13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/aps.2013.95","volume":"34","author":"YZ Ma","year":"2013","unstructured":"Ma YZ, Ning N, He WB, Li JW, Hu JF, Chu SF, et al. Claulansine F promotes neuritogenesis in PC12 cells via the ERK signaling pathway. Acta Pharmacol Sin. 2013;34:1499\u2013507.","journal-title":"Acta Pharmacol Sin"},{"key":"78_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejphar.2016.05.017","volume":"786","author":"JY Huang","year":"2016","unstructured":"Huang JY, Ma YZ, Yuan YH, Zuo W, Chu SF, Liu H, et al. Claulansine F promoted the neuronal differentiation of neural stem and progenitor cells through Akt\/GSK-3beta\/beta-catenin pathway. Eur J Pharmacol. 2016;786:72\u201384.","journal-title":"Eur J Pharmacol"},{"key":"78_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ejmech.2017.11.084","volume":"143","author":"Y Zang","year":"2017","unstructured":"Zang Y, Song X, Li C, Ma J, Chu S, Liu D, et al. Pyrano[3,2-a]carbazole alkaloids as effective agents against ischemic stroke in vitro and in vivo. Eur J Med Chem. 2017;143:438\u201348.","journal-title":"Eur J Med Chem"},{"key":"78_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2010.03.038","volume":"636","author":"HJ Ji","year":"2010","unstructured":"Ji HJ, Hu JF, Wang YH, Chen XY, Zhou R, Chen NH. Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus. Eur J Pharmacol. 2010;636:96\u2013101.","journal-title":"Eur J Pharmacol"},{"key":"78_CR17","first-page":"166","volume":"31","author":"XL Zhao","year":"2002","unstructured":"Zhao XL, Fang XB, Li DP. Establishing vascular dementia model in rats. J Chin Med Univ. 2002;31:166\u20137.","journal-title":"J Chin Med Univ"},{"key":"78_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejphar.2012.01.025","volume":"680","author":"XL He","year":"2012","unstructured":"He XL, Wang YH, Bi MG, Du GH. Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats. Eur J Pharmacol. 2012;680:41\u20138.","journal-title":"Eur J Pharmacol"},{"key":"78_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuropharm.2017.03.022","volume":"118","author":"T Zhang","year":"2017","unstructured":"Zhang T, Gu J, Wu L, Li N, Sun Y, Yu P, et al. Neuroprotective and axonal outgrowth-promoting effects of tetramethylpyrazine nitrone in chronic cerebral hypoperfusion rats and primary hippocampal neurons exposed to hypoxia. Neuropharmacology. 2017;118:137\u201347.","journal-title":"Neuropharmacology"},{"key":"78_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/089771502753460268","volume":"19","author":"T Sugawara","year":"2002","unstructured":"Sugawara T, Lewen A, Noshita N, Gasche Y, Chan PH. Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats. J Neurotrauma. 2002;19:85\u201398.","journal-title":"J Neurotrauma"},{"key":"78_CR21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/STROKEAHA.115.011679","volume":"47","author":"BR Choi","year":"2016","unstructured":"Choi BR, Kim DH, Back DB, Kang CH, Moon WJ, Han JS, et al. Characterization of white matter injury in a rat model of chronic cerebral hypoperfusion. Stroke. 2016;47:542\u20137.","journal-title":"Stroke"},{"key":"78_CR22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1089\/ars.2015.6508","volume":"24","author":"A Minno Di","year":"2016","unstructured":"Di Minno A, Turnu L, Porro B, Squellerio I, Cavalca V, Tremoli E, et al. 8-Hydroxy-2-deoxyguanosine levels and cardiovascular disease: a systematic review and meta-analysis of the literature. Antioxid Redox Signal. 2016;24:548\u201355.","journal-title":"Antioxid Redox Signal"},{"key":"78_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cccn.2003.09.010","volume":"339","author":"LL Wu","year":"2004","unstructured":"Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339:1\u20139.","journal-title":"Clin Chim Acta"},{"key":"78_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10059-011-0276-3","volume":"32","author":"YS Bae","year":"2011","unstructured":"Bae YS, Oh H, Rhee SG, Yoo YD. Regulation of reactive oxygen species generation in cell signaling. Mol Cells. 2011;32:491\u2013509.","journal-title":"Mol Cells"},{"key":"78_CR25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.dnarep.2004.03.002","volume":"3","author":"A Barzilai","year":"2004","unstructured":"Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amst). 2004;3:1109\u201315.","journal-title":"DNA Repair (Amst)"},{"key":"78_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.maturitas.2014.06.004","volume":"79","author":"CD Etherton-Beer","year":"2014","unstructured":"Etherton-Beer CD. Vascular cognitive impairment in dementia. Maturitas. 2014;79:220\u20136.","journal-title":"Maturitas"},{"key":"78_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainresrev.2007.01.003","volume":"54","author":"E Farkas","year":"2007","unstructured":"Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev. 2007;54:162\u201380.","journal-title":"Brain Res Rev"},{"key":"78_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1046\/j.1440-1681.2003.03825.x","volume":"30","author":"T Otori","year":"2003","unstructured":"Otori T, Katsumata T, Muramatsu H, Kashiwagi F, Katayama Y, Terashi A. Long-term measurement of cerebral blood flow and metabolism in a rat chronic hypoperfusion model. Clin Exp Pharmacol Physiol. 2003;30:266\u201372.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"78_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ntt.2014.07.003","volume":"45","author":"CV Vorhees","year":"2014","unstructured":"Vorhees CV, Williams MT. Value of water mazes for assessing spatial and egocentric learning and memory in rodent basic research and regulatory studies. Neurotoxicol Teratol. 2014;45:75\u201390.","journal-title":"Neurotoxicol Teratol"},{"key":"78_CR30","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.phymed.2016.10.005","volume":"23","author":"C Liu","year":"2016","unstructured":"Liu C, Yin H, Gao J, Xu X, Zhang T, Yang Z. Leonurine ameliorates cognitive dysfunction via antagonizing excitotoxic glutamate insults and inhibiting autophagy. Phytomedicine. 2016;23:1638\u201346.","journal-title":"Phytomedicine"},{"key":"78_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jneumeth.2009.07.010","volume":"184","author":"A Kadar","year":"2009","unstructured":"Kadar A, Wittmann G, Liposits Z, Fekete C. Improved method for combination of immunocytochemistry and Nissl staining. J Neurosci Methods. 2009;184:115\u20138.","journal-title":"J Neurosci Methods"},{"key":"78_CR32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3109\/00207454.2012.686543","volume":"122","author":"H Liu","year":"2012","unstructured":"Liu H, Zhang J. Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress. Int J Neurosci. 2012;122:494\u20139.","journal-title":"Int J Neurosci"},{"key":"78_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/JAD-2009-1041","volume":"17","author":"S Bennett","year":"2009","unstructured":"Bennett S, Grant MM, Aldred S. Oxidative stress in vascular dementia and Alzheimer\u2019s disease: a common pathology. J Alzheimers Dis. 2009;17:245\u201357.","journal-title":"J Alzheimers Dis"},{"key":"78_CR34","first-page":"109","volume":"20","author":"EE Dubinina","year":"2007","unstructured":"Dubinina EE, Kovrugina SV, Konovalov PV. The factors of oxidative stress in neurodegenerative diseases (vascular dementia, Alzheimer disease). Adv Gerontol. 2007;20:109\u201313.","journal-title":"Adv Gerontol"},{"key":"78_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00210-012-0790-7","volume":"385","author":"HA Kim","year":"2012","unstructured":"Kim HA, Miller AA, Drummond GR, Thrift AG, Arumugam TV, Phan TG, et al. Vascular cognitive impairment and Alzheimer\u2019s disease: role of cerebral hypoperfusion and oxidative stress. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2012;385:953\u20139.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"78_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1095\/biolreprod.110.088583","volume":"84","author":"J Lim","year":"2011","unstructured":"Lim J, Luderer U. Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary. Biol Reprod. 2011;84:775\u201382.","journal-title":"Biol Reprod"},{"key":"78_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0003489416675873","volume":"126","author":"MR Mazlumoglu","year":"2017","unstructured":"Mazlumoglu MR, Ozkan O, Alp HH, Ozyildirim E, Bingol F, Yoruk O, et al. Measuring oxidative DNA damage with 8-hydroxy-2\u2019-deoxyguanosine levels in patients with laryngeal cancer. Ann Otol Rhinol Laryngol. 2017;126:103\u20139.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"78_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3109\/1354750X.2014.910552","volume":"19","author":"JW Chien","year":"2014","unstructured":"Chien JW, Wang LY, Cheng YS, Tsai YG, Liu CS. Urinary 8-hydroxy-2\u2032-deoxyguanosine (8-oxodG) level can predict acute renal damage in young children with urinary tract infection. Biomarkers. 2014;19:326\u201331.","journal-title":"Biomarkers"},{"key":"78_CR39","first-page":"287","volume":"53","author":"R Mehrdad","year":"2015","unstructured":"Mehrdad R, Aghdaei S, Pouryaghoub G. Urinary 8-hydroxy-deoxyguanosine as a biomarker of oxidative DNA damage in employees of subway system. Acta Med Iran. 2015;53:287\u201392.","journal-title":"Acta Med Iran"},{"key":"78_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3748\/wjg.v18.i4.302","volume":"18","author":"CY Ock","year":"2012","unstructured":"Ock CY, Kim EH, Choi DJ, Lee HJ, Hahm KB, Chung MH. 8-Hydroxydeoxyguanosine: not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases. World J Gastroenterol. 2012;18:302\u20138.","journal-title":"World J Gastroenterol"},{"key":"78_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/aje\/kwq136","volume":"172","author":"X Gao","year":"2010","unstructured":"Gao X, Lai CQ, Scott T, Shen J, Cai T, Ordovas JM, et al. Urinary 8-hydroxy-2-deoxyguanosine and cognitive function in Puerto Rican adults. Am J Epidemiol. 2010;172:271\u20138.","journal-title":"Am J Epidemiol"},{"key":"78_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1017\/S0317167100012701","volume":"39","author":"GX Shi","year":"2012","unstructured":"Shi GX, Liu CZ, Wang LP, Guan LP, Li SQ. Biomarkers of oxidative stress in vascular dementia patients. Can J Neurol Sci. 2012;39:65\u20138.","journal-title":"Can J Neurol Sci"},{"key":"78_CR43","doi-asserted-by":"crossref","unstructured":"Kroese LJ, Scheffer PG. 8-Hydroxy-2'-deoxyguanosine and cardiovascular disease: a systematic review. Curr Atheroscler Rep. 2014;16:452","DOI":"10.1007\/s11883-014-0452-y"},{"key":"78_CR44","doi-asserted-by":"publisher","first-page":"504678","DOI":"10.1155\/2015\/504678","volume":"2015","author":"M Luca","year":"2015","unstructured":"Luca M, Luca A, Calandra C. The role of oxidative damage in the pathogenesis and progression of Alzheimer\u2019s disease and vascular dementia. Oxid Med Cell Longev. 2015;2015:504678.","journal-title":"Oxid Med Cell Longev"},{"key":"78_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2007.08.041","volume":"266","author":"D Gackowski","year":"2008","unstructured":"Gackowski D, Rozalski R, Siomek A, Dziaman T, Nicpon K, Klimarczyk M, et al. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease\/vascular dementia. J Neurol Sci. 2008;266:57\u201362.","journal-title":"J Neurol Sci"},{"key":"78_CR46","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/S0891-5849(03)00073-X","volume":"34","author":"A Hirayama","year":"2003","unstructured":"Hirayama A, Yoh K, Nagase S, Ueda A, Itoh K, Morito N, et al. EPR imaging of reducing activity in Nrf2 transcriptional factor-deficient mice. Free Radic Biol Med. 2003;34:1236\u201342.","journal-title":"Free Radic Biol Med"},{"key":"78_CR47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","volume":"88","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Yamamoto M. Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med. 2015;88:93\u2013100.","journal-title":"Free Radic Biol Med"},{"key":"78_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2013.02.008","volume":"66","author":"SK Niture","year":"2014","unstructured":"Niture SK, Khatri R, Jaiswal AK. Regulation of Nrf2\u2014an update. Free Radic Biol Med. 2014;66:36\u201344.","journal-title":"Free Radic Biol Med"},{"key":"78_CR49","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jnutbio.2015.08.001","volume":"26","author":"Y Huang","year":"2015","unstructured":"Huang Y, Li W, Su ZY, Kong AN. The complexity of the Nrf2 pathway: beyond the antioxidant response. J Nutr Biochem. 2015;26:1401\u201313.","journal-title":"J Nutr Biochem"},{"key":"78_CR50","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.biocel.2012.04.021","volume":"44","author":"SJ Chapple","year":"2012","unstructured":"Chapple SJ, Siow RC, Mann GE. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol. 2012;44:1315\u201320.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0078-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0078-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0078-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:18Z","timestamp":1684616478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0078-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0078-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"7 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}